Hippocrates; The use of FAPI-PET/CT and FDG-PET/CT scan in acute phase Peyronie’s disease for detection of active fibroblasts and inflammation in the penis - a pilot study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-518838-82-00

Acronym

Hippocrates

Enrollment

Registered

2024-12-05

Start date

2024-12-13

Completion date

Unknown

Last updated

2024-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peyronie's Disease

Brief summary

Detection of active fibroblasts or inflammation in the penis of new onset PD patients with FAPI-PET/CT scan and/or FDG-PET/CT scan.

Interventions

DRUG[68Ga]FAPI-46

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Detection of active fibroblasts or inflammation in the penis of new onset PD patients with FAPI-PET/CT scan and/or FDG-PET/CT scan.	—

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026